Investors

Insider Transactions

Date Name Title Type Shares Traded Price Range
Feb 21, 2012 powchik peter Officer Automatic Sell 60,612 100.32
Feb 21, 2012 powchik peter Officer Option Execute 109,866 15.64 - 21.92
Feb 16, 2012 mccorkle douglas s Officer Sell 5,353 107.50
Feb 15, 2012 gilman alfred g Director Sell 26,734 109.56
Feb 15, 2012 mccorkle douglas s Officer Sell 9,097 111.08
Feb 15, 2012 schleifer leonard s Officer Disposition (Non Open Market) 6,257 111.01
Feb 15, 2012 stahl neil Officer Sell 21,082 107.79 - 108.09
Feb 15, 2012 yancopoulos george Officer Disposition (Non Open Market) 67,017 109.29
Feb 15, 2012 yancopoulos george Officer Option Execute 133,332 8.50
Feb 14, 2012 gilman alfred g Director Disposition (Non Open Market) 3,266 111.01
Feb 14, 2012 gilman alfred g Director Option Execute 30,000 9.17 - 15.01
Feb 14, 2012 goldstein joseph l Director Automatic Sell 15,000 110.02
Feb 14, 2012 goldstein joseph l Director Option Execute 15,000 24.41 - 33.42
Feb 14, 2012 mccorkle douglas s Officer Sell 4,562 109.01 - 110.50
Feb 14, 2012 mccorkle douglas s Officer Disposition (Non Open Market) 15,988 111.01
Feb 14, 2012 mccorkle douglas s Officer Option Execute 35,000 16.80 - 21.92
Feb 14, 2012 schleifer leonard s Officer Disposition (Non Open Market) 263,478 111.01
Feb 14, 2012 schleifer leonard s Officer Option Execute 500,000 13.00 - 19.43
Feb 14, 2012 stahl neil Officer Disposition (Non Open Market) 28,918 111.01
Feb 14, 2012 stahl neil Officer Sell 31,202 107.83 - 113.47
Showing 381-400 of 790 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)